SCREEN for Type 1 Diabetes Act of 2026
Key claim: The SCREEN for Type 1 Diabetes Act of 2026 (HR9000) was introduced in the 119th Congress and referred to the House Committee on Energy and Commerce.
Abstract
(HR9000 · 119th Congress) Latest action (2026-05-21): Referred to the House Committee on Energy and Commerce.
Why this matters
Type 1 diabetes screening detects autoantibodies before symptomatic onset, potentially reducing diabetic ketoacidosis at diagnosis and enabling early intervention. A dedicated federal bill signals congressional interest in expanding access to and possibly coverage of screening, which could affect what pediatric and at-risk patients pay and which providers are reimbursed for it. As introduced legislation, the practical impact depends on committee action and any coverage or funding provisions that emerge.